Article
siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival.
Neoplasia (New York, N.Y.) - 1 Nov 2007
Zeng Gang, Apte Udayan, Cieply Benjamin, Singh Sucha, Monga Satdarshan P S
Abstract excerpt
beta-Catenin, the chief oncogenic component of the canonical Wnt pathway, is known to be involved in a variety of cancers, including hepatocellular carcinoma (HCC). Although the mechanism of beta-catenin activation in HCC is multifactorial, it is indisputably implicated at various stages of hepatocarcinogenesis, making it an attractive therapeutic target. Here we investigate the effect of small interfering...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
